Interim analysis of the multinational, post-authorisation safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma: Time to onset of adverse events
Saved in:
| Main Authors: | R. Gutzmer, P. Mohr, K. Kähler, P.A. Ascierto, M. Scalvenzi, K. Peris, G.M. Pérez-Pastor, R. Fernández-de-Misa, R. Botella Estrada, R. Hunger, S. Martelli, R. Arntz, A. Hauschild |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | EJC Skin Cancer |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772611824000326 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interim analysis of the multinational, post-authorization safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma
by: Ralf Gutzmer, et al.
Published: (2024-11-01) -
Sonidegib reduced tumor burden in patients with advanced basal cell carcinoma in the BOLT trial: Long-term analysis results
by: Michael R. Migden, et al.
Published: (2024-12-01) -
Management of muscle spasms induced by sonidegib in a 93-year-old patient with a multimodal gait disorder
by: C. Helf, et al.
Published: (2024-01-01) -
Real-life use of delamanid: results from the European post-authorisation safety study
by: N. Schönfeld, et al.
Published: (2024-06-01) -
Pharmacovigilance systems for safety monitoring of herbal medicines: assessment of the national regulatory authority, manufacturers and marketing authorisation holders in Tanzania
by: Alambo K. Mssusa, et al.
Published: (2025-12-01)